Combination of radiation and razoxane (ICRF 159) in vivo.
D000818:Animals; D005260:Female; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000532:radiotherapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy*; D010879:Piperazines / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011929:Razoxane / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000188:drug therapy / Q000532:radiotherapy
D010879:Piperazines; D011838:Radiation-Sensitizing Agents; D011929:Razoxane